Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Addition of chemoradiotherapy to palliative chemotherapy in de novo metastatic nasopharyngeal carcinoma: a real-world study

Fig. 2

OS for patients receiving different combinations of systemic and locoregional treatments after propensity score matching. A Different cycles of PCT. B Different regimens of concurrent chemotherapy. C Single-agent platinum versus radiotherapy alone after 4–6 cycles of PCT. OS overall survival, PCT palliative chemotherapy, CCRT concurrent chemoradiotherapy, RT radiotherapy

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us